GormanMPHealyBCPolgar-TurcsanyiM. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol2009; 66: 54–59.
2.
YehEAWeinstock-GuttmanBRamanathanM. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain2009; 132: 3392–3400.
3.
BanwellBBar-OrAArnoldDL. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol2011; 10: 436–445.
4.
AmatoMPGorettiBGhezziA. Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up. Neurology2010; 75: 1134–1140.
5.
JulianLSerafinDCharvetL. Cognitive impairment occurs in children and adolescents with multiple sclerosis: Results from a United States network. J Child Neurol2013; 28: 102–107.
6.
ChabasDCastillo-TrivinoTMowryEM. Vanishing MS T2-bright lesions before puberty: A distinct MRI phenotype?Neurology2008; 71: 1090–1093.
7.
SadakaYVerheyLHShroffMM. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol2012; 72: 211–223.
8.
ChabasDNessJBelmanA. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology2010; 74: 399–405.
9.
Vargas-LowyDKivisakkPGandhiR. Increased Th17 response to myelin peptides in pediatric MS. Clin Immunol2012; 146: 176–184.
10.
ChitnisTTenembaumSBanwellB. Consensus statement: Evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler2012; 18: 116–127.
11.
ChitnisTTardieuMAmatoMP. International Pediatric MS Study Group Clinical Trials Summit: Meeting report. Neurology2013; 80: 1161–1168.
